Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × tipifarnib × Clear all

NCT03719690 2024-06-21

AIM-HN/SEQ-HN

Phase 2 Completed

296 enrolled 27 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms